{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:35:24Z","timestamp":1770896124861,"version":"3.50.1"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7,1]]},"DOI":"10.1097\/qai.0b013e318068d151","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T07:01:38Z","timestamp":1187334098000},"page":"S38-S46","source":"Crossref","is-referenced-by-count":16,"title":["Diagnosis and Management of Cirrhosis in Coinfected Patients"],"prefix":"10.1097","volume":"45","author":[{"given":"Maurizio","family":"Bonacini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.","volume":"32","author":"Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"issue":"Suppl 2","key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/381453","article-title":"Liver injury during highly active antiretroviral therapy: the effect of hepatitis C coinfection.","volume":"38","author":"Bonacini","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R4-3-20210131","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/432762","article-title":"Influence of hepatitis C on HIV disease progression and response to highly active antiretroviral therapy.","volume":"192","author":"Rockstroh","year":"2005","journal-title":"J Infect Dis"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Mocroft A, de Wit S, et al, for the EuroSIDA Group. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.","volume":"19","author":"Konopnicki","year":"2005","journal-title":"AIDS"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/377135","article-title":"Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects.","volume":"188","author":"Kellerman","year":"2003","journal-title":"J Infect Dis"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.aids.0000200537.86984.0e","article-title":"Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.","volume":"20","author":"Lacombe","year":"2006","journal-title":"AIDS"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1086\/380130","article-title":"Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European Collaborative Study.","volume":"38","author":"Martin-Carbonero","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.aids.0000198087.47454.e1","article-title":"Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.","volume":"20","author":"Merchante","year":"2006","journal-title":"AIDS"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20626","article-title":"HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.","volume":"41","author":"Pineda","year":"2005","journal-title":"Hepatology"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1097\/00002030-200410210-00008","article-title":"Survival in patients with HIV infection and viral hepatitis B or C: a cohort study.","volume":"18","author":"Bonacini","year":"2004","journal-title":"AIDS"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/501021","article-title":"Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C: assessment using transient elastometry and the role of HCV genotype 3.","volume":"42","author":"Barreiro","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2005.07.006","article-title":"Slower fibrosis progression in HIV\/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.","volume":"44","author":"Brau","year":"2006","journal-title":"J Hepatol"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.52.7.1035","article-title":"Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.","volume":"52","author":"Mohsen","year":"2003","journal-title":"Gut"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0168-8278(02)00413-0","article-title":"A comparison of fibrosis progression in chronic liver diseases.","volume":"38","author":"Poynard","year":"2003","journal-title":"J Hepatol"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1086\/317644","article-title":"Liver fibrosis progression is related to CD4 cells depletion in patients with hepatitis C virus and HIV coinfection.","volume":"183","author":"Puoti","year":"2001","journal-title":"J Infect Dis"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.aids.0000210606.63138.f5","article-title":"Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.","volume":"20","author":"Bani-Sadr","year":"2006","journal-title":"AIDS"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.aids.0000163935.99401.25","article-title":"Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.","volume":"19","author":"Sulkowski","year":"2005","journal-title":"AIDS"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1086\/497608","article-title":"Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.","volume":"192","author":"Marks","year":"2005","journal-title":"J Infect Dis"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/S0140-6736(03)14844-1","article-title":"Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.","volume":"362","author":"Qurishi","year":"2003","journal-title":"Lancet"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.","volume":"30","author":"Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/499055","article-title":"Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients?","volume":"42","author":"Verma","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.","volume":"42","author":"Ratnam","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jhep.2005.03.003","article-title":"Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV coinfected patients.","volume":"42","author":"Alberti","year":"2005","journal-title":"J Hepatol"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference.","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R32-3-20210131","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM199708143370707","article-title":"Treatment of hepatic encephalopathy.","volume":"337","author":"Riordan","year":"1997","journal-title":"N Engl J Med"},{"key":"R33-3-20210131","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.sla.0000171327.29262.e0","article-title":"Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis.","volume":"242","author":"Northrup","year":"2005","journal-title":"Ann Surg"},{"key":"R34-3-20210131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.qai.0000194238.15831.c7","article-title":"Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV\/hepatitis C virus-coinfected patients.","volume":"41","author":"de Ledinghen","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-3-20210131","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/gut.2005.068585","article-title":"Non-invasive evaluation of hepatic fibrosis: dont count your chickens before theyre hatched.","volume":"55","author":"Pinzani","year":"2006","journal-title":"Gut"},{"key":"R36-3-20210131","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1468-1293.2005.00330.x","article-title":"Validation of a simple model for predicting liver fibrosis in HIV\/hepatitis C virus-coinfected patients.","volume":"6","author":"Al-Morhi","year":"2005","journal-title":"HIV Med"},{"key":"R37-3-20210131","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R38-3-20210131","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.","volume":"128","author":"Castera","year":"2005","journal-title":"Gastroenterology"},{"key":"R39-3-20210131","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.","volume":"41","author":"Ziol","year":"2005","journal-title":"Hepatology"},{"key":"R40-3-20210131","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites.","volume":"350","author":"Gines","year":"2004","journal-title":"N Engl J Med"},{"key":"R41-3-20210131","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.20066","article-title":"Management of adult patients with ascites due to cirrhosis.","volume":"39","author":"Runyon","year":"2004","journal-title":"Hepatology"},{"key":"R43-3-20210131","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"R44-3-20210131","first-page":"207","article-title":"The role of real-time ultrasonography in predicting esophageal varices in hemophiliacs co-infected with hepatitis C and human immunodeficiency virus.","volume":"90","author":"Dragoni","year":"2005","journal-title":"Haematologica"},{"key":"R46-3-20210131","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study.","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"R47-3-20210131","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.mcg.0000159222.16032.98","article-title":"Beta blocker prophylaxis for patients with variceal hemorrhage.","volume":"39","author":"Wilbur","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R48-3-20210131","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"key":"R49-3-20210131","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00042737-200510000-00016","article-title":"Endoscopic variceal ligation vs propranolol for prevention of first variceal bleeding: a randomized controlled trial.","volume":"17","author":"Psilopoulos","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R50-3-20210131","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2005.01.047","article-title":"Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices.","volume":"128","author":"Jutabha","year":"2005","journal-title":"Gastroenterology"},{"key":"R51-3-20210131","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1007\/s10620-005-2877-1","article-title":"Evaluation of endoscopic variceal ligation (EVL) versus propranolol plus isosorbide mononitrate\/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.","volume":"50","author":"Sarin","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R52-3-20210131","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.510290608","article-title":"Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.","volume":"29","author":"Bernard","year":"1999","journal-title":"Hepatology"},{"key":"R53-3-20210131","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.21145","article-title":"A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation.","volume":"43","author":"Tan","year":"2006","journal-title":"Hepatology"},{"key":"R54-3-20210131","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome.","volume":"362","author":"Gines","year":"2003","journal-title":"Lancet"},{"key":"R55-3-20210131","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1572-0241.2001.03964.x","article-title":"Cordoba J, and the Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy.","volume":"96","author":"Blei","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R56-3-20210131","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/bmj.38048.506134.EE","article-title":"Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.","volume":"328","author":"Als-Nielsen","year":"2004","journal-title":"BMJ"},{"key":"R57-3-20210131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-8278(02)00350-1","article-title":"Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.","volume":"38","author":"Mas","year":"2003","journal-title":"J Hepatol"},{"key":"R57A-3-20210131","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"AASLD Practice Guideline. Management of hepatocellular carcinoma.","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"R58-3-20210131","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cgh.2005.12.024","article-title":"Biopsy of suspicious liver nodules: does it change management?","volume":"4","author":"Crippin","year":"2006","journal-title":"Clin Gastro Hepatol"},{"key":"R59-3-20210131","first-page":"399A","article-title":"Short-term mortality and tumor necrosis after locoregional therapy for hepatocellular carcinoma (HCC) in OLT recipients [abstract 565].","volume":"44","author":"Kohla","year":"2006","journal-title":"Hepatology"},{"key":"R60-3-20210131","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2005.04.009","article-title":"A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.","volume":"129","author":"Shiina","year":"2005","journal-title":"Gastroenterology"},{"key":"R61-3-20210131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/341084","article-title":"Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.","volume":"186","author":"Wit","year":"2002","journal-title":"J Infect Dis"},{"key":"R62-3-20210131","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00126334-200303010-00004","article-title":"Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome.","volume":"32","author":"Puoti","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R63-3-20210131","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-138-3-200302040-00012","article-title":"Hepatitis C in the HIV-infected person.","volume":"138","author":"Sulkowski","year":"2003","journal-title":"Ann Intern Med"},{"key":"R64-3-20210131","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/379254","article-title":"Survival of human immunodeficiency virus-infected liver transplant recipients.","volume":"188","author":"Ragni","year":"2003","journal-title":"J Infect Dis"},{"issue":"Suppl","key":"R65-3-20210131","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0168-8278(06)80014-0","article-title":"Liver transplantation of HIV-HCV and HIV-HBV coinfected patients: a large experience in a single centre [abstract].","volume":"44","author":"Duclos Vallee","year":"2006","journal-title":"J Hepatol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200707012-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:19:29Z","timestamp":1618039169000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200707012-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,1]]},"references-count":61,"journal-issue":{"issue":"Supplement 2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318068d151","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7,1]]}}}